Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (새로운 창 열기)

Cid J, Ortín X, Elies E, Díaz E.

Source‎: Transfus Apher Sci 2003;28(1):101-2.

Indexed‎: PubMed 12620275

DOI‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 (새로운 창 열기)

Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange. (새로운 창 열기)

Dabak V, Kuriakose P, Raman S.

Source‎: J Clin Apher 2007;22(6):330-2.

Indexed‎: PubMed 18080270

DOI‎: 10.1002/jca.20150

https://www.ncbi.nlm.nih.gov/pubmed/18080270 (새로운 창 열기)

Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia. (새로운 창 열기)

Jordan SD, Alexander E.

Source‎: J Pharm Pract 2013;26(3):257-60.

Indexed‎: PubMed 22869910

DOI‎: 10.1177/0897190012451928

https://www.ncbi.nlm.nih.gov/pubmed/22869910 (새로운 창 열기)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (새로운 창 열기)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Source‎: Leuk Res Rep. 2022 25;18:100355.

Indexed‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (새로운 창 열기)

The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. (새로운 창 열기)

Waddington DP, McAuley FT, Hanley JP, Summerfield GP.

Source‎: Br J Haematol 2002;119(1):286-8.

Indexed‎: PubMed 12358947

https://www.ncbi.nlm.nih.gov/pubmed/12358947 (새로운 창 열기)

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness. (새로운 창 열기)

Walia SS, Walia MS, Walia HS.

Source‎: Asian J Transfus Sci 2011;5(2):180-1.

Indexed‎: PubMed 21897605

DOI‎: 10.4103/0973-6247.83255

https://www.ncbi.nlm.nih.gov/pubmed/21897605 (새로운 창 열기)